Masahide Ohmichi - Concepedia

Author

Masahide Ohmichi

Osaka Medical and Pharmaceutical University

Also Known As

M Ohmichi, MASAHIDE OHMICHI, Masahide OHMICHI, Masahide Ohmichi, Ohmichi Masahide

310

Publications

7.7K

Citations

H-Index

178

Concepts

All Affiliations

Osaka Medical and Pharmaceutical University The University of Osaka Yamagata University Kindai University Kanazawa University

About

Masahide Ohmichi is an author at Osaka Medical and Pharmaceutical University specializing in medicine, cell biology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	68	2.8K
2	Public Health	15	19	639
3	Health Sciences	7	7	163
4	Natural Sciences	1	1	54
5	Social Sciences	1	1	28

Masahide Ohmichi

152

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells Koji Hisamoto, Masahide Ohmichi, Hirohisa Kurachi, Journal of Biological Chemistry	2001	378
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Jun Hayakawa, Masahide Ohmichi, Hirohisa Kurachi, PubMed Kinase B/akt-bad CascadeBad PhosphorylationCancer BiologyTumor BiologyOvarian Cancer	2000	249
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models Seiji Mabuchi, Masahide Ohmichi, Yukihiro Nishio, Journal of Biological Chemistry	2004	212
Estrogen Suppresses Transcription of Lipoprotein Lipase Gene Hiroaki Homma, Hirohisa Kurachi, Yukihiro Nishio, Journal of Biological Chemistry	2000	207
Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell Line Jun Hayakawa, Masahide Ohmichi, Hirohisa Kurachi, Journal of Biological Chemistry	1999	174
Inhibition of Phosphorylation of BAD and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to Paclitaxel Seiji Mabuchi, Masahide Ohmichi, Akiko Kimura, Journal of Biological Chemistry	2002	171
The Activation of c-Jun NH2-terminal Kinase (JNK) by DNA-damaging Agents Serves to Promote Drug Resistance via Activating Transcription Factor 2 (ATF2)-dependent Enhanced DNA Repair Jun Hayakawa, Chantal Depatie, Masahide Ohmichi, Journal of Biological Chemistry	2003	163
mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary Seiji Mabuchi, Chiaki Kawase, Deborah A. Altomare, Clinical Cancer Research	2009	155
Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines Akiko Kimura, Masahide Ohmichi, Jun Kawagoe, Oncogene Hormonal ReceptorAkt CascadeGynecologyHtert ExpressionRadiation Oncology	2004	146
Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway Yoshiko Maida, Satoru Kyo, Taro Kanaya, Oncogene Signal TransductionDevelopmental BiologySignaling PathwayReceptor Tyrosine KinaseMap Kinase	2002	145

Page 1